ACLARIS THERAPEUTICS INC
ACRS·00461U105·US·Common Stock·Healthcare - Biotechnology-13D/G
ACRS (ACLARIS THERAPEUTICS INC) is held by 88 institutional investors as of Q2 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($67.3M), BlackRock, Inc. ($53.1M), VANGUARD CAPITAL MANAGEMENT LLC ($30.8M). Net institutional sentiment: Bullish.
88
Holders
(7 Elite)
$321.8M
Total Value
67% (91)
Consensus
62 buying - 29 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 2, 2026 · Insiders May 5, 2026 · Activists Sep 21, 2026 · Congress none
ActivistFLFrazier Life Sciences Public Fund, L.P.5.4%Sep 21, 2026
ActivistVOVivo Opportunity Fund Holdings, L.P.4.3%May 12, 2026
Checking access…
Top Holders
Checking access…
Showing 1-20 of 96
1 / 5
Continue exploring
Other Healthcare stocks held by institutions
415 holders · $876.7B
415 holders · $298.4B
400 holders · $151.2B
397 holders · $413.6B
394 holders · $97.5B
393 holders · $111.1B
390 holders · $229.8B
385 holders · $302.3B
385 holders · $51.7B
382 holders · $113.5B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer